SCHEMBL23488267

SCHEMBL23488267

CS(C)(C)CCO[C@@H]1O[C@H](COC(=O)c2ccc(OCc3ccccc3)cc2)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.47
CHRNB2 P17787 1/20 0.46
CHRNA5 P30532 1/20 0.46
CHRNA7 P36544 1/20 0.46
CHRNA4 P43681 1/20 0.46
XDH P47989 1/20 0.45
TYMP P19971 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
HIF1A Q16665 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NR4A1 P22736 1/20 0.40
NR4A2 P43354 1/20 0.40
NR4A3 Q92570 1/20 0.40
SYNJ2 O15056 3/20 0.40
PARP10 Q53GL7 1/20 0.39
SRD5A2 P31213 1/20 0.38
SLC22A1 O15245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488265 0.88 MAOB (0.48) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488137 0.88 XDH (0.41) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488460 0.88 CHRNB2 (0.49) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488257 0.87 MAOB (0.40) MAOBXDHTYMPTDP1
SCHEMBL23488668 0.85 CHRNB2 (0.51) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488128 0.85 CHRNB2 (0.51) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488262 0.85 CHRNB2 (0.51) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488254 0.83 CHRNB2 (0.45) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488151 0.82 TDP1 (0.53) MAOBCHRNB2CHRNA5CHRNA7CHRNA4
SCHEMBL23488173 0.81 CHRNB2 (0.53) MAOBCHRNB2CHRNA5CHRNA7CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 MAOB 4123/4885CHRNB2 3085/4885CHRNA5 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.